Veterinary Vaccine Adjuvants Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-05-06　·　154 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 410 Mn
2033 年預估規模: USD 640 Mn
年複合成長率 CAGR: 6.6%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-05-06頁數 154報告編號 CMI9471

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Veterinary Vaccine Adjuvants Market, By Product Type (Aluminum-based Adjuvants, Oil-based Adjuvants, Emulsion-based Adjuvants, and Others), By Animal Type (Livestock Animals and Companion Animals), By Route of Administration (Injectable, Oral, and Intranasal), By Application (Bacterial Vaccines, Viral Vaccines, and Parasitic Vaccines), By End User (Veterinary Pharmaceutical and Biopharmaceutical Companies, Contract Research and Manufacturing Organizations (CROs/CMOs), Research and Academic Institutes, and Veterinary Clinics and Hospitals), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

報告摘要

The global veterinary vaccine adjuvants market is estimated to be valued at USD 410 Mn in 2026 and is expected to reach USD 640 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033. Veterinary vaccine adjuvants are important constituents that ensure better performance, stability and improved efficacy of animal vaccines. They help boost the immunity levels in livestock and pets and provide a significant impact on the effectiveness of the vaccines. The increasing threat of zoonosis, rising livestock numbers, and greater focus on preventive care for animals are the major drivers behind the demand for sophisticated adjuvants in all regions around the world. The global veterinary vaccines adjuvants market is dominated by a wide range of products such as oil emulsions, polymer-based systems, and nanoparticle-based formulations. The market is moving towards newer technologies in the creation of adjuvants and their usage in animal vaccines. Growing pet ownership, higher awareness about animal vaccination, and favorable government policies in support of animal immunization are the main factors influencing market dynamics. The introduction of new technology in the field of immunology and the inclusion of adjuvants in multivalent and species-specific vaccines will also offer lucrative opportunities in the coming years. Market Dynamics The veterinary vaccine adjuvants market is propelled by the rising incidences of infectious and zoonotic diseases among farm and companion animals. As a result, there is an increasing need for immunization strategies. With the rapid development of livestock production due to increasing protein demands around the world, the role of preventing infections and diseases becomes especially important, which leads to the greater implementation of immunizations based on vaccine adjuvants. Additionally, the increase in pets' numbers and pet owners' interest in animal health, alongside their expenditures on veterinary healthcare, leads to the increase in vaccine products use. Nonetheless, the industry is faced with several limitations, such as strict regulation in terms of product approval, development, and safety standards, which might slow down the process and lead to extra costs. Moreover, individual differences between animal species and adverse reactions to conventional adjuvants constitute additional barriers. Additionally, there is insufficient availability of advanced healthcare solutions and infrastructure in less developed countries. Nevertheless, there are numerous growth opportunities on the market because of innovations, including new-generation vaccine adjuvants, the increased interest of government agencies and international organizations in vaccination programs; and the rise in preventive animal care. Key Features of the Study • This report provides in-depth analysis of the global veterinary vaccine adjuvants market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global veterinary vaccine adjuvants market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Zoetis Inc., Merck Animal Health, Elanco Animal Health, Ceva Santé Animale, Boehringer Ingelheim Animal Health, HIPRA, Phibro Animal Health Corporation, Virbac, Vaxxinova, and Seppic • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global veterinary vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccine adjuvants market Market Segmentation • Product Type Insights (Revenue, USD Mn, 2021 - 2033) o Aluminum-based Adjuvants o Oil-based Adjuvants o Emulsion-based Adjuvants o Others • Animal Type Insights (Revenue, USD Mn, 2021 - 2033) o Livestock Animals o Companion Animals • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033) o Injectable o Oral o Intranasal • Application Insights (Revenue, USD Mn, 2021 - 2033) o Bacterial Vaccines o Viral Vaccines o Parasitic Vaccines • End User Insights (Revenue, USD Mn, 2021 - 2033) o Veterinary Pharmaceutical and Biopharmaceutical Companies o Contract Research and Manufacturing Organizations (CROs/CMOs) o Research and Academic Institutes o Veterinary Clinics and Hospitals • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Zoetis Inc. o Merck Animal Health o Elanco Animal Health o Ceva Santé Animale o Boehringer Ingelheim Animal Health o HIPRA o Phibro Animal Health Corporation o Virbac o Vaxxinova o Seppic

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Veterinary Vaccine Adjuvants Market, By Product Type  Global Veterinary Vaccine Adjuvants Market, By Animal Type  Global Veterinary Vaccine Adjuvants Market, By Route of Administration  Global Veterinary Vaccine Adjuvants Market, By Application  Global Veterinary Vaccine Adjuvants Market, By End User  Global Veterinary Vaccine Adjuvants Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Veterinary Vaccine Adjuvants Market, By Product Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Aluminum-based Adjuvants  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Oil-based Adjuvants  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Emulsion-based Adjuvants  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Veterinary Vaccine Adjuvants Market, By Animal Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Livestock Animals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Companion Animals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Veterinary Vaccine Adjuvants Market, By Route of Administration, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Injectable  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Oral  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Intranasal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Veterinary Vaccine Adjuvants Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Bacterial Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Viral Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Parasitic Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Veterinary Vaccine Adjuvants Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Veterinary Pharmaceutical and Biopharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Contract Research and Manufacturing Organizations (CROs/CMOs)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Research and Academic Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Veterinary Clinics and Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Veterinary Vaccine Adjuvants Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o Zoetis Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck Animal Health  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Elanco Animal Health  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Ceva Sante Animale  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Boehringer Ingelheim Animal Health  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o HIPRA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Phibro Animal Health Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Virbac  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Vaxxinova  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Seppic  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 11. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Veterinary Vaccine Adjuvants Market' - Global forecast to 2033

提及公司

Zoetis Inc.Merck Animal HealthElanco Animal HealthCeva Santé AnimaleBoehringer Ingelheim Animal HealthHIPRAPhibro Animal Health CorporationVirbacVaxxinovaSeppic

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們